login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
BIOMARIN PHARMACEUTICAL INC (BMRN) Stock News
USA
- NASDAQ:BMRN -
US09061G1013
-
Common Stock
54.87
USD
+0.14 (+0.26%)
Last: 11/17/2025, 1:06:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
BMRN Latest News, Press Relases and Analysis
All
Press Releases
12 days ago - By: Chartmill
BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) Presents a Compelling Value Investment Case
11 days ago - By: Benzinga
- Mentions:
ELF
KRNT
ZBH
DUOL
This Zimmer Biomet Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
19 days ago - By: BioMarin Pharmaceutical Inc.
FDA Accepts BioMarin's PALYNZIQ® (pegvaliase-pqpz) Supplemental Biologics License Application for Priority Review to Expand Use to Adolescents Aged 12-17 with Phenylketonuria
20 days ago - By: The Motley Fool
Why BioMarin Pharmaceutical Stock Topped the Market on Tuesday
21 days ago - By: The Motley Fool
BioMarin (BMRN) Q3 2025 Earnings Call Transcript
21 days ago - By: BioMarin Pharmaceutical Inc.
BioMarin Reports Third Quarter 2025 Results and Provides Corporate Update
24 days ago - By: Benzinga
What to Expect from Biomarin Pharmaceutical's Earnings
25 days ago - By: Zacks Investment Research
- Mentions:
GILD
Gilead Sciences (GILD) Earnings Expected to Grow: Should You Buy?
26 days ago - By: BioMarin Pharmaceutical Inc.
BioMarin to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Monday, October 27, 2025, at 4:30pm ET
2 months ago - By: Zacks Investment Research
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
2 months ago - By: Zacks Investment Research
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
2 months ago - By: Zacks Investment Research
Are Options Traders Betting on a Big Move in BioMarin Pharmaceutical Stock?
2 months ago - By: BioMarin Pharmaceutical Inc.
BioMarin Shares New Data Reinforcing Its Leadership in Bone Health at the American Society for Bone and Mineral Research Annual Meeting
Please enable JavaScript to continue using this application.